Table 1.
Demographic | Total | Group 1 PV |
Group 2 No PV |
p Value |
---|---|---|---|---|
Age (years) | n = 138 | n = 45 | n = 93 | |
Mean (SD) | 64.4 (6.7) | 65.2 (8.2) | 64.1 (5.8) | 0.4 |
Range | 37–79 | 37–79 | 48–77 | |
Education | n = 140 | n = 44 | n = 96 | |
Non-tertiary | 86 (61.4) | 26 (59.1) | 60 (62.5) | 0.7 |
Tertiary | 54 (38.6) | 18 (40.9) | 36 (37.5) | |
Income (per annum) | n = 140 | n = 44 | n = 96 | |
<$90,000AUD | 83 (59.3) | 23 (52.3) | 60 (62.5) | 0.3 |
>$90,000AUD | 57 (40.7) | 21 (47.7) | 36 (37.5) | |
Relationship | n = 141 | n = 45 | n = 96 | |
Partnered | 118 (83.7) | 39 (86.7) | 79 (82.3) | 0.5 |
Not partnered | 23 (16.3) | 6 (13.3) | 17 (17.7) | |
Children | n = 141 | n = 45 | n = 96 | |
Yes | 118 (83.7) | 42 (93.3) | 76 (79.2) | 0.03 * |
No | 23 (16.3) | 3 (6.7) | 20 (20.8) | |
Pathogenic variant | n = 141 | n = 45 | n = 96 | |
Not detected | 96 (68.1) | 0 (0) | 96 (100) | |
ATM | 1 (0.7) | 1 (2.2) | 0 (0) | |
BRCA1 | 2 (1.4) | 2 (4.4) | 0 (0) | |
BRCA2 | 24 (17.0) | 24 (53.3) | 0 (0) | |
PALB2 | 15 (10.6) | 15 (33.3) | 0 (0) | |
HBOC predisposition/Cannot recall | 3 (2.1) a | 3 (6.6) a | 0 (0) | |
Mean time since notification of genetic information (years) | n = 141 | n = 45 | n = 96 | |
Mean (SD) | n/a | 1.7 (1.5) | n/a | |
Range | n/a | 0.2–5.1 | n/a | |
Cancer history | n = 141 | n = 45 | n = 96 | |
No cancer | 126 (89.4) | 30 (66.7) | 96 (100) | |
Breast cancer | 9 (6.4) | 9 (20.0) | 0 (0) | |
Ovarian cancer | 1 (0.7) | 1 (2.2) | 0 (0) | |
Other cancer | 5 3.6) | 5 (11.1) | 0 (0) |
a Two had not had confirmatory clinical genetic testing at the time of the study and one could not specifically recall her result; * Denotes statistically significant result (p < 0.05).